Credit Suisse’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $2.82M | Buy |
|
|||||
|
2023
Q4 | $1.75M | Buy |
|
|||||
|
2023
Q3 | $1.11M | Sell |
|
|||||
|
2023
Q2 | $771K | Buy |
|
|||||
|
2023
Q1 | $509K | Buy |
|
|||||
|
2022
Q4 | $543K | Sell |
|
|||||
|
2022
Q3 | $611K | Buy |
|
|||||
|
2022
Q2 | $511K | Buy |
|
|||||
|
2022
Q1 | $547K | Buy |
|
|||||
|
2021
Q4 | $577K | Buy |
|
|||||
|
2021
Q3 | $304K | Buy |
|
|||||
|
2021
Q2 | $269K | Buy |
|
|||||
|
2021
Q1 | $160K | Sell |
|
|||||
|
2020
Q4 | $261K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $211K | Buy |
|